CytoMed Therapeutics Limited Equity Attributable To Owners Of Parent
CytoMed Therapeutics Limited (GDTC) had Equity Attributable To Owners Of Parent of SGD 6.54 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:EquityAttributableToOwnersOfParent · last filed 2026-03-31
- 2025-12-31: Equity Attributable To Owners Of Parent 6.54M SGD.
- 2024-12-31: Equity Attributable To Owners Of Parent 8.97M SGD.
- 2023-12-31: Equity Attributable To Owners Of Parent 11.25M SGD.
- 2022-12-31: Equity Attributable To Owners Of Parent 586.98K SGD.
SGD
| Period end | Equity Attributable To Owners Of Parent |
|---|---|
| 2025-12-31 | 6.54M SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 8.97M SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 11.25M SGD 20-F · filed 2025-04-28 |
| 2022-12-31 | 586.98K SGD 20-F · filed 2024-04-22 |
| 2021-12-31 | 2.59M SGD 20-F · filed 2023-05-01 |
USD
| Period end | Equity Attributable To Owners Of Parent |
|---|---|
| 2025-12-31 | $5.09M 20-F · filed 2026-03-31 |
| 2024-12-31 | $6.56M 20-F · filed 2025-04-28 |
| 2023-12-31 | $8.52M 20-F · filed 2024-04-22 |
| 2022-12-31 | $437.91K 20-F · filed 2023-05-01 |